Paratek Pharmaceuticals, Inc.
PRTK · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $126,594 | $144,535 | $101,705 | $141,778 |
| - Cash | $42,685 | $45,026 | $34,248 | $27,087 |
| + Debt | $259,756 | $259,070 | $258,414 | $259,103 |
| Enterprise Value | $343,665 | $358,579 | $325,871 | $373,794 |
| Revenue | $38,062 | $29,208 | $72,627 | $27,845 |
| % Growth | 30.3% | -59.8% | 160.8% | – |
| Gross Profit | $33,694 | $22,964 | $62,315 | $23,473 |
| % Margin | 88.5% | 78.6% | 85.8% | 84.3% |
| EBITDA | -$9,169 | -$15,559 | -$2,456 | -$16,215 |
| % Margin | -24.1% | -53.3% | -3.4% | -58.2% |
| Net Income | -$14,553 | -$20,143 | -$7,157 | -$25,269 |
| % Margin | -38.2% | -69% | -9.9% | -90.7% |
| EPS Diluted | -0.25 | -0.35 | -0.13 | -0.46 |
| % Growth | 28.6% | -169.2% | 71.7% | – |
| Operating Cash Flow | -$1,776 | $11,090 | -$20,113 | -$12,419 |
| Capital Expenditures | $0 | -$32 | -$36 | $0 |
| Free Cash Flow | -$1,776 | $11,058 | -$20,149 | -$12,419 |